Function | Gene symbol | Gene description | Fold changea | |
---|---|---|---|---|
ToF | ASD | |||
Trascription regulation | ATF3 | Activating transcription factor 3 | 35.8 | 13.4 |
EGR3 | Early growth response 3 | 27.0 | 13.0 | |
NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | 20.7 | 18.2 | |
NR4A3 | Nuclear receptor subfamily 4, group A, member 3 | 19.6 | 4.8 | |
FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 14.9 | 28.8 | |
MAFF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F | 12.0 | 8.4 | |
JUNB | Jun B proto-oncogene | 10.3 | 9.4 | |
EGR2 | Early growth response 2 | 9.8 | 5.9 | |
EGR1 | Early growth response 1 | 8.8 | 20.5 | |
NR4A1 | Nuclear receptor subfamily 4, group A, member 1 | 6.5 | 5.3 | |
NFKBIZ | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 6.3 | 2.2 | |
MYC | v-myc avian myelocytomatosis viral oncogene homolog | 6.0 | 3.8 | |
FOS | FBJ murine osteosarcoma viral oncogene homolog | 5.9 | 13.9 | |
JUN | Jun proto-oncogene | 5.9 | 3.9 | |
KLF4 | Kruppel-like factor 4 (gut) | 5.7 | 4.5 | |
CSRNP1 | Cysteine-serine-rich nuclear protein 1 | 5.6 | 4.8 | |
IER3 | Immediate early response 3 | 4.6 | 2.3 | |
FOSL2 | FOS-like antigen 2 | 4.5 | 2.8 | |
IER2 | Immediate early response | 2 4.0 | 5.0 | |
HES1 | Hes family bHLH transcription factor 1 | 3.9 | 2.2 | |
NFIL3 | Nuclear factor, interleukin 3 regulated | 3.9 | 2.4 | |
KLF2 | Kruppel-like factor 2 | 2.3 | 2.2 | |
Regulation of cell growth and apoptosis | MIR21/VMP1 | MicroRNA 21/vacuole membrane protein 1 | 11.4 | 5 |
DUSP5 | Dual specificity phosphatase 5 | 5.4 | 3.1 | |
GADD45B | Growth arrest and DNA-damage-inducible, beta | 5.2 | 2.6 | |
CDKN1A | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 5.1 | 2.7 | |
MIR22/MIR22HG | MicroRNA 22/MIR22 host gene | 4.5 | 2.8 | |
MCL1 | Myeloid cell leukemia 1 | 4.4 | 2.5 | |
MIR23A/MIR24-2 | MicroRNA 23a/24-2 | 4.3 | 3.3 | |
BTG2 | BTG family, member 2 | 4.0 | 2.6 | |
DUSP6 | Dual specificity phosphatase 6 | 3.7 | 3.2 | |
CCNL1 | Cyclin L1 | 3.7 | 2 | |
PPP1R15A/GADD34 | Protein phosphatase 1, regulatory subunit 15A/growth arrest and DNA-damage-inducible | 3.3 | 2.1 | |
DUSP1 | Dual specificity phosphatase 1 | 2.2 | 2.1 | |
Inflammatory response | SOCS3 | Suppressor of cytokine signaling 3 | 23.0 | 24.6 |
PTGS2 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 12.2 | 6.9 | |
CCL2 | Chemokine (C–C motif) ligand 2 | 10.4 | 6.2 | |
CXCL2 | Chemokine (C–X–C motif) ligand 2 | 9.3 | 11.7 | |
RGS1 | Regulator of G-protein signaling 1 | 4.0 | 4.8 | |
RGS2 | Regulator of G-protein signaling 2 | 3.6 | 2.0 | |
C3 | Complement component 3 | 0.4 | 0.3 | |
ITLN1 | Intelectin 1 (galactofuranose binding) | 0.05 | 0.1 | |
Cell adhesion and matrix organization | ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 6.5 | 3.8 |
CYR61 (CCN1) | Cysteine-rich, angiogenic inducer, 61 | 5.5 | 5.2 | |
THBD | Thrombomodulin | 4.6 | 2.4 | |
EFEMP1 | EGF containing fibulin-like extracellular matrix protein 1 | 0.4 | 0.4 | |
COL3A1 | Collagen, type III, alpha 1 | 0.2 | 0.2 | |
Antioxidant activity | MT1M | Metallothionein 1M | 14.3 | 5.9 |
NCOA7 | Nuclear receptor coactivator 7 | 4.7 | 2.2 | |
MT2A | Metallothionein 2A | 3.1 | 2.0 |